Hypertension:高血压患者癌症死亡风险升高

2012-03-03 MedSci MedSci原创

  欧洲学者的一项研究表明,高血压男性患者的总体癌症风险轻度升高;高血压男、女性患者的癌症死亡风险均升高。论文于2012年2月21日在线发表于《高血压》(Hypertension)杂志。   观察性研究在血压和癌症风险相关性方面显示了不一致的结果。此项研究在来自于挪威、奥地利和瑞典的7个人群中调查了上述相关性。平均年龄为44岁的 577799例成人接受了平均12年的随访。伴发癌症的男、女性患者分

  欧洲学者的一项研究表明,高血压男性患者的总体癌症风险轻度升高;高血压男、女性患者的癌症死亡风险均升高。论文于2012年2月21日在线发表于《高血压》(Hypertension)杂志。

  观察性研究在血压和癌症风险相关性方面显示了不一致的结果。此项研究在来自于挪威、奥地利和瑞典的7个人群中调查了上述相关性。平均年龄为44岁的 577799例成人接受了平均12年的随访。伴发癌症的男、女性患者分别为22184和14744例,癌症死亡者分别为8724和4525例。

  分析显示,在男性中,中位血压与总体偶发癌症呈正相关(每升高10 mmHg危险比1.07),并与口腔、结肠、直肠、肺、膀胱和肾脏癌症以及恶性黑色素瘤和非黑色素瘤皮肤癌呈正相关。在女性中,中位血压与总体偶发癌症无相关性,但与肝脏、胰腺、宫颈和子宫癌症以及恶性黑色素瘤呈正相关。癌症死亡率亦与中位血压升高呈正相关,男性和女性危险比分别为1.12和1.06。

  链接:

  Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1725407, encodeId=03481e2540713, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 02 17:07:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038438, encodeId=1c192038438ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 26 18:07:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045318, encodeId=baac204531815, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Sep 09 18:07:00 CST 2012, time=2012-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255393, encodeId=257f12553936a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448102, encodeId=1744144810212, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500996, encodeId=b522150099626, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=)]
    2012-08-02 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1725407, encodeId=03481e2540713, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 02 17:07:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038438, encodeId=1c192038438ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 26 18:07:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045318, encodeId=baac204531815, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Sep 09 18:07:00 CST 2012, time=2012-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255393, encodeId=257f12553936a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448102, encodeId=1744144810212, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500996, encodeId=b522150099626, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1725407, encodeId=03481e2540713, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 02 17:07:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038438, encodeId=1c192038438ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 26 18:07:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045318, encodeId=baac204531815, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Sep 09 18:07:00 CST 2012, time=2012-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255393, encodeId=257f12553936a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448102, encodeId=1744144810212, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500996, encodeId=b522150099626, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1725407, encodeId=03481e2540713, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 02 17:07:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038438, encodeId=1c192038438ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 26 18:07:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045318, encodeId=baac204531815, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Sep 09 18:07:00 CST 2012, time=2012-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255393, encodeId=257f12553936a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448102, encodeId=1744144810212, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500996, encodeId=b522150099626, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1725407, encodeId=03481e2540713, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 02 17:07:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038438, encodeId=1c192038438ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 26 18:07:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045318, encodeId=baac204531815, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Sep 09 18:07:00 CST 2012, time=2012-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255393, encodeId=257f12553936a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448102, encodeId=1744144810212, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500996, encodeId=b522150099626, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1725407, encodeId=03481e2540713, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Aug 02 17:07:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038438, encodeId=1c192038438ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue Jun 26 18:07:00 CST 2012, time=2012-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045318, encodeId=baac204531815, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Sep 09 18:07:00 CST 2012, time=2012-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255393, encodeId=257f12553936a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448102, encodeId=1744144810212, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500996, encodeId=b522150099626, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Mon Mar 05 02:07:00 CST 2012, time=2012-03-05, status=1, ipAttribution=)]

相关资讯

器械治疗难治性高血压的研究进展

    关键字:顽固性高血压 难治性高血压    顽固性高血压(Resistant hypertension)又称难治性高血压(refractory hypertension),给社会带来沉重的经济和医疗负担。尽管目前流行病学调查的确切数值还不是很明晰,但有研究指出,在现有的高血压人群中顽固性高血压患者占到了20-30%(1-3

高血压联合治疗的理论与实践

    高血压是最常见的心血管病,是全球范围内的重大公共卫生问题。全球有近10亿以上的高血压患者。据世界卫生组织预测,至2020年,非传染性疾病将占我国死亡原因的79%,其中心血管病将占首位[1]。我国的高血压的防治面临着严峻的形势,高血压的知晓率、治疗率和控制率很低。最近的资料显示上述指标有所改善,但远未到达理想目标。因此高血压患者的血压达标已经成为目前高血压治疗中

CNSR研究:高血压独立预测小动脉闭塞亚型卒中复发

 在2012年国际卒中大会上,来自我国首都医科大学天坛医院的一项临床研究证实,高血压是卒中小动脉闭塞(SAO)亚型复发独立预测因素,但非大动脉粥样硬化及心因性卒中亚型复发的预测因素。该研究强调了SAO亚型卒中患者控制高血压的重要性,旨在减少在中国人群中的卒中复发事件。   高血压能否导致缺血性卒中复发仍是全球激辩的热点问题,而中国关注于此的研究较少。中国国家卒中注册研究(CNSR研究)是中国第

从“降压治疗”到“血压管理”

    高血压已经成为威胁人类健康和生命的最常见的慢性心血管疾病,中国的高血压患者已经超过2亿人,高血压可以带来严重的并发症而导致死亡与残废,并且由于高血压早期可能没有任何症状而延误治疗,因此,高血压又被称为“无声杀手”。由于高血压的危害已经被认识,并且降压治疗的益处又被许多大型临床试验所证明,所有,降压是硬道理已经成为共识。然而,受流行病学资料的影响和人们的许多美好

王继光:从指南谈起——关注病理生理 合理防控高血压

 2011 年,我国发布了《2010 版 中国高血压防治指南》,英国发表了新版《NICE 成人原发性高血压指南》,加上这几年来对“美国高血压指南(JNC8)”的等待或期许,可以预见,有关这些指南的讨论将是2012年高血压领域的重点关注话题。   王继光,男,博士,教授,博士生导师。现任上海交通大学医学院附属瑞金医院临床试验与流行病学研究中心主任、上海市高

2012国际卒中大会:中国CNSR研究结果发表

       2012年国际卒中大会上,我国首都医科大学天坛医院王拥军等开展的一项临床研究证实,高血压是卒中小动脉闭塞(SAO)亚型复发独立预测因素,但非大动脉粥样硬 化及心因性卒中亚型复发的预测因素。该研究强调了SAO亚型卒中患者控制高血压的重要性,旨在减少在中国人群中的卒中复发事件。 高血压能否导致缺血性卒中复发仍是全球激辩的热点问题,而中国关注于